Attributing increased prevalence of facial palsy to SARS-CoV-2 requires evidence.

Finsterer, Josef; Scorza, Fúlvio A; Scorza, Carla A; Fiorini, Ana C

Finsterer, Josef; Scorza, Fúlvio A; Scorza, Carla A; Fiorini, Ana C.

Finsterer J; Klinik Landstrasse, Messerli Institute, Vienna, Austria.
Scorza FA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
Scorza CA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
Fiorini AC; Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), São Paulo, Brazil.

Brain Behav ; 11(2): e01996, 2021 02.

Article in English | MEDLINE | ID: covidwho-973319

Subject(s)

COVID-19; Facial Paralysis; Facial Paralysis/epidemiology; Facial Paralysis/etiology; Humans; Pandemics; Prevalence; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; facial palsy; nerves; neuropathy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Facial Paralysis / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Brain Behav Year: 2021 Document Type: Article Affiliation country: Brb3.1996

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google